IRE1 activators (Lead Discovery Center/INSERM/McGill University/Semmelweis University)

N/A

Report date: 2025/01/26 15:42:15
NME

Base Information

Drug NameIRE1 activators (Lead Discovery Center/INSERM/McGill University/Semmelweis University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase/endoribonuclease IRE1 stimulants
TargetsSerine/threonine-protein kinase/endoribonuclease IRE1
Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaHungaryGermany +[4] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitut National De La Sante Et De La Recherche Medicale
China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Sante Et De La Recherche MedicaleLead Discovery Center GmbHSemmelweis University +[4] 
Inactive CompaniesN/A
Active Indicationsalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A